An early study found that obese children with non-alcoholic fatty liver disease who received probiotic medication had significantly lower levels of alanine aminotransferase and anti-peptidoglycan-polysaccharide antibodies than those who received a placebo [44]. This evidence concerns the gene GPT and alcoholic fatty liver disease.